Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07184814

Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
China-Japan Friendship Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to identify the clinical features, management pattern and long-term outcomes of patients with pulmonary arteries involvement in Takayasu's arteritis (TAK-PAI).

Detailed description

The present study intends to conduct a prospective analysis of the clinical data in TAK patients in order to: 1. describe the clinical characteristics and current status of multimodal treatment in patients with TAK-PAI, thereby enhancing the understanding of TAK-PAI; 2. to investigate the risk factors for mortality in patients with TAK-PAI, so as to promote early intervention and reduce mortality. 3. explore factors associated with pulmonary hypertention (PH) in patients with TAK-PAI, so as to facilitate the early identification of patients who may develop PH.

Conditions

Timeline

Start date
2016-01-01
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2025-09-22
Last updated
2025-09-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07184814. Inclusion in this directory is not an endorsement.

Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement (NCT07184814) · Clinical Trials Directory